TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 73 filers reported holding TANGO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,131,044 | +280.9% | 11,645,741 | +12.3% | 0.01% | +266.7% |
| Q2 2023 | $34,424,403 | -54.2% | 10,368,796 | -45.5% | 0.00% | 0.0% |
| Q1 2023 | $75,120,538 | +14.1% | 19,017,858 | +109.4% | 0.00% | -57.1% |
| Q4 2022 | $65,856,673 | +158.5% | 9,083,679 | +29.1% | 0.01% | +133.3% |
| Q3 2022 | $25,479,000 | -26.3% | 7,038,340 | -7.8% | 0.00% | 0.0% |
| Q2 2022 | $34,572,000 | -33.7% | 7,631,917 | +11.0% | 0.00% | -25.0% |
| Q1 2022 | $52,120,000 | -33.7% | 6,875,975 | -4.3% | 0.00% | -33.3% |
| Q4 2021 | $78,574,000 | -2.8% | 7,182,188 | +14.9% | 0.01% | 0.0% |
| Q3 2021 | $80,838,000 | – | 6,251,913 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $218,038,359 | 82.15% |
| Nextech Invest Ltd. | 5,533,980 | $62,312,615 | 18.88% |
| Boxer Capital, LLC | 7,123,642 | $80,212,209 | 4.27% |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $32,571,385 | 3.64% |
| EcoR1 Capital, LLC | 8,721,636 | $98,205,621 | 3.31% |
| Samsara BioCapital, LLC | 630,000 | $7,093,800 | 2.17% |
| Soleus Capital Management, L.P. | 1,929,019 | $21,720,754 | 2.00% |
| Casdin Capital, LLC | 1,307,349 | $14,720,750 | 1.63% |
| Southpoint Capital Advisors LP | 5,276,699 | $59,415,631 | 1.33% |
| Affinity Asset Advisors, LLC | 350,000 | $3,941,000 | 1.11% |